CureVac hires GSK Vaccines veteran Blanc as CBO and chief commercial officer; plus moves at Spero, 4D, Transgene, Achilles and Datavant

mRNA play  CureVac N.V. (NASDAQ:CVAC) hired Antony Blanc as CBO and chief commercial officer. Blanc most recently was managing director at Clarentis s.r.l., and prior to that VP, global integration lead at the GSK Vaccines unit of  GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) in 2014-17.

Tamara Joseph joined antibiotics company Spero Therapeutics Inc. (NASDAQ:SPRO) as chief legal officer. She was general counsel at  Millendo Therapeutics Inc. (NASDAQ:MLND)...